Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Arrowhead Pharmaceuticals Inc. (ARWR)

34.12   -2.27 (-6.24%) 02-25 16:00
Open: 37 Pre. Close: 36.39
High: 37.57 Low: 34
Volume: 1,657,953 Market Cap: 3468M
Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 37.815 - 38.178 38.178 - 38.398
Low: 33.282 - 33.724 33.724 - 33.991
Close: 33.617 - 34.331 34.331 - 34.762

Technical analysis

as of: 2020-02-25 4:27:18 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 53.25     One year: 61.61
Support: Support1: 34.00    Support2: 28.29
Resistance: Resistance1: 45.59    Resistance2: 52.75
Pivot: 40.50
Moving Average: MA(5): 37.73     MA(20): 41.18
MA(100): 49.06     MA(250): 34.49
MACD: MACD(12,26): -3.94     Signal(9): -3.84
Stochastic oscillator: %K(14,3): 5.05     %D(3): 9.03
RSI: RSI(14): 21.53
52-week: High: 73.72  Low: 17.27  Change(%): 73.2
Average Vol(K): 3-Month: 225030  10-Days: 122904

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ARWR has closed below the lower band by 13.0%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 27.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Arrowhead Pharmaceuticals Reports Fiscal 2020 First Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals Reports Fiscal 2020 First Quarter Results

Arrowhead (ARWR) to Report Q1 Earnings: What's in the Cards?
We expect Arrowhead (ARWR) to provide pipeline updates when it releases first-quarter fiscal 2020 results.

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101.65
Shares Float (M) 98.91
% Held by Insiders 2.70
% Held by Institutions 63.82
Shares Short (K) 11120
Shares Short P. Month (K)

Stock Financials

EPS 0.530
Book Value (p.s.) 4.950
PEG Ratio -32.94
Profit Margin 32.56
Operating Margin 27.75
Return on Assets (ttm) 6.1
Return on Equity (ttm) 15.9
Qtrly Rev. Growth -15.0
Gross Profit (p.s.) 1.661
Sales Per Share
EBITDA (p.s.) 0.491
Qtrly Earnings Growth
Operating Cash Flow (M) -18.78
Levered Free Cash Flow (M) -30.34

Stock Valuations

P/E 64.38
P/E Growth Ratio -0.06
P/BV 6.89
P/S 19.83
P/CF -184.68

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2011-11-16
Last Split Ratio 0.1
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.